Sinopharm Group Co. Ltd. (SHTDY)
Sinopharm Statistics
Share Statistics
Sinopharm has 634.08M shares outstanding. The number of shares has increased by -0.33% in one year.
| Shares Outstanding | 634.08M |
| Shares Change (YoY) | -0.33% |
| Shares Change (QoQ) | -0.4% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 6 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 6.38 and the forward PE ratio is null. Sinopharm's PEG ratio is 0.96.
| PE Ratio | 6.38 |
| Forward PE | n/a |
| PS Ratio | 0.1 |
| Forward PS | n/a |
| PB Ratio | 0.77 |
| P/FCF Ratio | 3.89 |
| PEG Ratio | 0.96 |
Enterprise Valuation
Sinopharm has an Enterprise Value (EV) of 298.65B.
| EV / Sales | 0.5 |
| EV / EBITDA | 11.1 |
| EV / EBIT | 17.39 |
| EV / FCF | 20.13 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.39 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 2.74 |
| Debt / FCF | 4.97 |
| Interest Coverage | 6.84 |
Financial Efficiency
Return on Equity is 12.14% and Return on Invested Capital is 7.83%.
| Return on Equity | 12.14% |
| Return on Assets | 2.36% |
| Return on Invested Capital | 7.83% |
| Revenue Per Employee | $5,512,715.79 |
| Profits Per Employee | $83,663.01 |
| Employee Count | 108,217 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 9.13 |
Taxes
| Income Tax | 4.5B |
| Effective Tax Rate | 23.07% |
Stock Price Statistics
The stock price has increased by -7.19% in the last 52 weeks. The beta is 0.63, so Sinopharm's price volatility has been higher than the market average.
| Beta | 0.63 |
| 52-Week Price Change | -7.19% |
| 50-Day Moving Average | 11.97 |
| 200-Day Moving Average | 12.5 |
| Relative Strength Index (RSI) | 49.97 |
| Average Volume (20 Days) | 20,072 |
Income Statement
In the last 12 months, Sinopharm had revenue of 596.57B and earned 9.05B in profits. Earnings per share was 14.5.
| Revenue | 596.57B |
| Gross Profit | 48.51B |
| Operating Income | 20.21B |
| Net Income | 9.05B |
| EBITDA | 26.9B |
| EBIT | 22.47B |
| Earnings Per Share (EPS) | 14.5 |
Balance Sheet
The company has 63.81B in cash and 73.78B in debt, giving a net cash position of -9.97B.
| Cash & Cash Equivalents | 63.81B |
| Total Debt | 73.78B |
| Net Cash | -9.97B |
| Retained Earnings | 51.2B |
| Total Assets | 429.58B |
| Working Capital | 99.12B |
Cash Flow
In the last 12 months, operating cash flow was 17.17B and capital expenditures -2.34B, giving a free cash flow of 14.84B.
| Operating Cash Flow | 17.17B |
| Capital Expenditures | -2.34B |
| Free Cash Flow | 14.84B |
| FCF Per Share | 4.76 |
Margins
Gross margin is 8.13%, with operating and profit margins of 3.39% and 1.52%.
| Gross Margin | 8.13% |
| Operating Margin | 3.39% |
| Pretax Margin | 3.27% |
| Profit Margin | 1.52% |
| EBITDA Margin | 4.51% |
| EBIT Margin | 3.39% |
| FCF Margin | 2.49% |
Dividends & Yields
SHTDY pays an annual dividend of $0.6, which amounts to a dividend yield of 4.48%.
| Dividend Per Share | $0.60 |
| Dividend Yield | 4.48% |
| Dividend Growth (YoY) | 0.84% |
| Payout Ratio | 38.77% |
| Earnings Yield | 15.68% |
| FCF Yield | 5.14% |
Analyst Forecast
Currently there are no analyst rating for SHTDY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.99 |
| Piotroski F-Score | 5 |